# MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients

> **NCT06492369** · — · COMPLETED · sponsor: **Tanta University** · enrollment: 382 (actual)

## Conditions studied

- Metabolic- Associated Fatty Liver Disease (MAFLD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06492369
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-15
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-03-01
- **Target enrollment:** 382 (ACTUAL)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06492369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06492369, "MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT06492369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*